Elevation Point Wealth Partners LLC Acquires 14,530 Shares of HCA Healthcare, Inc. $HCA

Elevation Point Wealth Partners LLC increased its stake in HCA Healthcare, Inc. (NYSE:HCA) by 217.8% during the first quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 21,202 shares of the company’s stock after purchasing an additional 14,530 shares during the quarter. Elevation Point Wealth Partners LLC’s holdings in HCA Healthcare were worth $10,034,000 at the end of the most recent quarter.

Other institutional investors have also recently made changes to their positions in the company. Nordea Investment Management AB lifted its position in shares of HCA Healthcare by 11.2% in the fourth quarter. Nordea Investment Management AB now owns 1,084,590 shares of the company’s stock valued at $507,393,000 after acquiring an additional 108,849 shares in the last quarter. Nomura Asset Management Co. Ltd. boosted its position in shares of HCA Healthcare by 6.2% during the fourth quarter. Nomura Asset Management Co. Ltd. now owns 64,237 shares of the company’s stock worth $29,990,000 after acquiring an additional 3,724 shares during the last quarter. Hudson Bay Capital Management LP boosted its holdings in shares of HCA Healthcare by 154.5% during the 3rd quarter. Hudson Bay Capital Management LP now owns 4,693 shares of the company’s stock valued at $2,000,000 after purchasing an additional 2,849 shares during the last quarter. Advisors Capital Management LLC lifted its position in shares of HCA Healthcare by 61.5% in the fourth quarter. Advisors Capital Management LLC now owns 6,836 shares of the company’s stock worth $3,192,000 after buying an additional 2,604 shares in the last quarter. Finally, CWA Asset Management Group LLC boosted its position in shares of HCA Healthcare by 1,062.4% during the 4th quarter. CWA Asset Management Group LLC now owns 9,555 shares of the company’s stock valued at $4,461,000 after acquiring an additional 8,733 shares during the last quarter. Institutional investors own 62.73% of the company’s stock.

HCA Healthcare Price Performance

HCA Healthcare stock opened at $409.99 on Friday. The stock has a market cap of $90.95 billion, a price-to-earnings ratio of 14.10, a price-to-earnings-growth ratio of 1.25 and a beta of 1.12. The firm has a 50-day moving average of $401.89 and a two-hundred day moving average of $462.80. HCA Healthcare, Inc. has a 1 year low of $330.00 and a 1 year high of $556.52.

HCA Healthcare (NYSE:HCA) last announced its quarterly earnings results on Friday, April 24th. The company reported $7.15 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $7.19 by ($0.04). HCA Healthcare had a net margin of 8.89% and a negative return on equity of 295.93%. The company had revenue of $19.11 billion during the quarter, compared to analysts’ expectations of $19.09 billion. During the same quarter in the prior year, the business posted $6.45 earnings per share. The company’s revenue was up 4.3% compared to the same quarter last year. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. Research analysts expect that HCA Healthcare, Inc. will post 30.07 earnings per share for the current year.

HCA Healthcare Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, June 30th. Stockholders of record on Tuesday, June 16th were given a $0.78 dividend. The ex-dividend date of this dividend was Tuesday, June 16th. This represents a $3.12 dividend on an annualized basis and a dividend yield of 0.8%. HCA Healthcare’s dividend payout ratio (DPR) is presently 10.73%.

Analysts Set New Price Targets

Several research firms have commented on HCA. Deutsche Bank Aktiengesellschaft lowered their price objective on shares of HCA Healthcare from $558.00 to $540.00 and set a “buy” rating for the company in a research report on Tuesday, April 28th. Barclays dropped their price target on HCA Healthcare from $551.00 to $496.00 and set an “overweight” rating for the company in a research report on Monday, April 27th. JPMorgan Chase & Co. lowered their price objective on HCA Healthcare from $535.00 to $490.00 and set a “neutral” rating for the company in a research note on Tuesday, May 19th. Cantor Fitzgerald reissued an “overweight” rating on shares of HCA Healthcare in a research report on Wednesday. Finally, Leerink Partners dropped their price objective on shares of HCA Healthcare from $573.00 to $500.00 and set an “outperform” rating for the company in a research note on Monday, April 27th. Fifteen analysts have rated the stock with a Buy rating, eight have issued a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average price target of $503.00.

HCA Healthcare Company Profile

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.